TY  - GEN 
AU  - Haupenthal, Frederik
AU  - Rahn, Jette
AU  - Maggi, Fabrizio
AU  - Gelas, Fanny
AU  - Bourgeois, Philippe
AU  - Hugo, Christian
AU  - Jilma, Bernd
AU  - Böhmig, Georg A.
AU  - Herkner, Harald
AU  - Wolzt, Michael
AU  - Doberer, Konstantin
AU  - Vossen, Matthias
AU  - Focosi, Daniele
AU  - Neuwirt, Hannes
AU  - Banas, Miriam
AU  - Banas, Bernhard
AU  - Budde, Klemens
AU  - Viklicky, Ondrej
AU  - Malvezzi, Paolo
AU  - Rostaing, Lionel
AU  - Rotmans, Joris I.
AU  - Bakker, Stephan J.L
AU  - Eller, Kathrin
AU  - Cejka, Daniel
AU  - Molina Pérez, Alberto
AU  - Rodríguez Arias Vailhen, David
AU  - König, Franz
AU  - Bond, Gregor
PY  - 2023
UR  - https://hdl.handle.net/10481/97899
AB  - Background
Immunosuppression after kidney transplantation is mainly guided via plasma tacrolimus trough level, which cannot sufficiently predict allograft rejection and infection. The plasma load of the non-pathogenic and highly prevalent torque teno...
LA  - eng
PB  - Springer Nature
KW  - Kidney transplantation
KW  - Torque teno virus
KW  - inmunosupression
KW  - Tacrolimus
KW  - inmunological monitoring
KW  - personalised medicine
KW  - infection
KW  - Graft rejection
TI  - A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT
DO  - 10.1186/s13063-023-07216-0
ER  -